Urogen Pharma, INC.
Biopharmaceutical company
Based in NJ
AI Overview
With $470K in lobbying spend across 16 quarterly filings, Urogen Pharma, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2022 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $140K |
| 2023 | $120K |
| 2024 | $90K |
| 2025 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Urogen Pharma, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Provide strategic counsel and advocacy for issues related to cancer and urologic disease treatments and regulatory reimbursement policy around requirement for manufacturers to provide refunds to Medic
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.